Cellectar Biosciences Inc.
CLRB | NASDAQ
$2.34
-$0.01 (-0.43%)
Sep 22, 2026, 10:52 AM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | -110.02K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | 110.02K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -7.2M | -5.79M | -5.69M | -4.85M | -6.04M | -6.4M | -12.74M | -13.33M | -13.7M | -12M | -12.55M | -9.41M | -8.29M | -8.71M | -7.42M | -7.82M | -7.44M | -6.14M | -5.92M | -5.82M | -6.03M | -6.36M |
Interest Income | 133.36K | 63K | 97.58K | 112.54K | 88.02K | 136.96K | 244.21K | 317.89K | 328.91K | 319.85K | 139.22K | 51.11K | 72.78K | 124.03K | 147.44K | 4.16K | 481 | 430 | n/a | 590 | 659 | 2.36K |
Pretax Income | -6.93M | -5.65M | -5.3M | -4.44M | -5.45M | -6.6M | -2.29M | -14.66M | -919.37K | -26.64M | -7.94M | -17.52M | -10.18M | -7.19M | -12.47M | -7.81M | -7.44M | -6.14M | -5.92M | -5.82M | -6.03M | -6.36M |
Net Income | -6.93M | -5.65M | -5.3M | -4.44M | -5.45M | -6.6M | -2.36M | -14.66M | -919.37K | -26.64M | -7.88M | -17.52M | -10.18M | -7.19M | -12.41M | -7.81M | -7.44M | -6.14M | -5.92M | -5.82M | -6.03M | -6.36M |
Selling & General & Admin | 2.64M | 2.9M | 2.53M | 2.33M | 3.65M | 2.97M | 6.54M | 7.83M | 6.36M | 4.91M | 4.61M | 2.38M | 2.16M | 2.35M | 1.97M | 2.44M | 2.94M | 2.25M | 1.54M | 1.88M | 1.4M | 1.73M |
Research & Development | 4.56M | 3.01M | 3.16M | 2.52M | 2.39M | 3.43M | 6.21M | 5.49M | 7.35M | 7.09M | 7.94M | 7.03M | 6.14M | 6.36M | 5.45M | 5.38M | 4.5M | 3.89M | 4.39M | 3.94M | 4.63M | 4.63M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 7.2M | 5.9M | 5.69M | 4.85M | 6.04M | 6.4M | 12.74M | 13.33M | 13.7M | 12M | 12.55M | 9.41M | 8.29M | 8.71M | 7.42M | 7.82M | 7.44M | 6.14M | 5.92M | 5.82M | 6.03M | 6.36M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 7.2M | 5.79M | 5.69M | 4.85M | 6.04M | 6.4M | 12.74M | 13.33M | 13.7M | 12M | 12.55M | 9.41M | 8.29M | 8.71M | 7.42M | 7.82M | 7.44M | 6.14M | 5.92M | 5.82M | 6.03M | 6.36M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | 66K | n/a | n/a | n/a | -60K | n/a | n/a | n/a | -60K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 12.23M | 4.24M | 4.24M | 3.16M | 1.61M | 1.54M | 1.4M | 1.31M | 169K | 978.22K | 647.37K | 376.96K | 375.37K | 375.37K | 310.2K | 203.67K | 203.67K | 203.67K | 203.67K | 199.56K | 175.88K | 160.46K |
Shares Outstanding (Diluted) | 12.23M | 4.24M | 4.24M | 3.16M | 1.61M | 1.54M | 1.4M | 1.31M | 1.25M | 978.22K | 647.37K | 376.96K | 375.37K | 375.37K | 310.2K | 203.67K | 203.67K | 203.67K | 203.67K | 199.56K | 175.88K | 160.46K |
EPS (Basic) | -0.57 | -1.33 | -1.25 | -1.41 | -3.39 | -4.30 | -1.68 | -11.18 | -0.77 | -27.24 | -12.17 | -46.48 | -27.12 | -19.16 | -40 | -38.35 | -36.51 | -30.15 | -29.06 | -29.16 | -34.27 | -39.62 |
EPS (Diluted) | -0.57 | -1.33 | -1.25 | -1.41 | -3.39 | -4.30 | -1.68 | -11.18 | -5.43 | -27.24 | -12.17 | -46.48 | -27.12 | -19.16 | -40 | -38.35 | -36.51 | -30.15 | -29.06 | -29.16 | -34.27 | -39.62 |
EBITDA | -6.93M | -5.76M | -5.25M | -4.39M | -5.39M | -6.55M | -2.22M | -14.6M | -853.35K | -26.55M | -7.87M | -17.48M | -10.14M | -7.15M | -12.43M | -7.78M | -7.4M | -6.1M | -5.88M | -5.78M | -5.99M | -6.32M |
EBIT | -6.93M | -5.65M | -5.3M | -4.44M | -5.45M | -6.6M | -2.29M | -14.66M | -919.37K | -26.64M | -7.94M | -17.52M | -10.18M | -7.19M | -12.47M | -7.81M | -7.44M | -6.14M | -5.92M | -5.82M | -6.03M | -6.36M |
Depreciation & Amortization | n/a | -110.02K | 49.46K | 52.28K | 55.56K | 56.3K | 68.57K | 68.57K | 66.02K | 88.49K | 69.96K | 41.21K | 38.65K | 42.56K | 38.16K | 32.96K | 33.9K | 43.42K | 39.29K | 36.79K | 38.71K | 35.13K |
Add to Watchlist
Select watchlists to add or remove CLRB